Endothelial Progenitor Cells as a Sole Source for Ex Vivo Seeding of Tissue-Engineered Heart Valves
Name
Sales-2010-Endothelial Progenit.pdf
Size
708.84 KB
Format
Adobe PDF
Checksum (MD5)
545164033938d7332243d36f893afd22
Author(s)
Sales, Virna L.
Mettler, Bret A.
Engelmayr, George C.
Aikawa, Elena
Bischoff, Joyce
Martin, David P.
Exarhopoulos, Alexis
Moses, Marsha A.
Schoen, Frederick J.
Sacks, Michael S.
Date Issued
January 2010
Journal
Tissue Engineering. Part A
Publisher
Mary Ann Liebert, Inc.
Citation
Sales, Virna L. et al. “Endothelial Progenitor Cells as a Sole Source for Ex Vivo Seeding of Tissue-Engineered Heart Valves.” Tissue Engineering Part A 16.1 (2011) : 257-267. ©Mary Ann Liebert, Inc., publishers.
Version
Final published version
Abstract
Purposes: We investigated whether circulating endothelial progenitor cells (EPCs) can be used as a cell source for the creation of a tissue-engineered heart valve (TEHV). Methods: Trileaflet valved conduits were fabricated using nonwoven polyglycolic acid/poly-4-hydroxybutyrate polymer. Ovine peripheral blood EPCs were dynamically seeded onto a valved conduit and incubated for 7, 14, and 21 days. Results: Before seeding, EPCs were shown to express CD31+, eNOS+, and VE-Cadherin+ but not [alpha]-smooth muscle actin. Histological analysis demonstrated relatively homogenous cellular ingrowth throughout the valved conduit. TEHV constructs revealed the presence of endothelial cell (EC) markers and α-smooth muscle actin+ cells comparable with native valves. Protein levels were comparable with native valves and exceeded those in unseeded controls. EPC-TEHV demonstrated a temporal pattern of matrix metalloproteinases-2/9 expression and tissue inhibitors of metalloproteinase activities comparable to that of native valves. Mechanical properties of EPC-TEHV demonstrated significantly greater stiffness than that of the unseeded scaffolds and native valves. Conclusions: Circulating EPC appears to have the potential to provide both interstitial and endothelial functions and could potentially serve as a single-cell source for construction of autologous heart valves.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1089/ten.tea.2009.0424
